Observational study on epilepsy in western Sweden
Official title: Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment
Run by Sahlgrenska University Hospital · NCT04559919 · Data updated 2026-11-12
This study looks at adults in western Sweden who have had seizures or epilepsy to see if there are specific markers or genes that can help with their diagnosis and treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Sahlgrenska University Hospital Academic / other |
| Locations | 3 sites (Borås and 2 other locations) |
| Status | Recruiting |
| Started | November 27, 2020 |
| Main results expected | December 31, 2031 |
| Study ends | December 31, 2031 |
| Registry record updated | June 13, 2025 |
| Trial ID | NCT04559919 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years of age who have experienced an unprovoked seizure in the last year or have a diagnosis of epilepsy.
✕Probably not a fit
Patients with expected survival of less than two years or those unable to give informed consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows adults with an unprovoked seizure or epilepsy in western Sweden to identify biomarkers and genetic predispositions relevant for diagnosis and treatment. It collects baseline data and outcome variables from various patient registries, including electronic medical records and national health registers. The aim is to understand the long-term prognosis and consequences of epilepsy in this population.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for patients with epilepsy.
How similar studies have gone: Other studies have shown success in identifying biomarkers for epilepsy, making this approach promising yet still requiring further exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Over 18 years of age * An unprovoked seizure within the last year or a diagnosis of epilepsy according to the current International League Against Epilepsy definition (epilepsy with seizure in the last ten or antiepileptic drug treatment in the last five years) Exclusion Criteria: * Expected survival less than two years * Inability to give informed consent
Where it's running
-
Södra Älvsborgs Sjukhus
Borås, Sweden Recruiting -
Sahlgrenska University Hospital
Gothenburg, Sweden Recruiting -
Sjukhusen i Väster
Gothenburg, Sweden Recruiting
Study contacts
- Principal investigator: Johan Zelano, MD PhD — Sahlgrenska University Hospital
- Study coordinator: Johan Zelano, MD PhD
- Email: johan.zelano@vgregion.se
- Phone: +46313421000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
RAP-219 long-acting injectable safety and PK study in healthy adults
This early study tests RAP-219-LAI in healthy adults to see how it behaves in the body and whether it is safe and tolerable.
-
Why People with Epilepsy Get More Infections
This study tests whether anti-seizure medicines affect immune function and infection risk in people with epilepsy.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Hypothalamus structure and heart autonomic changes in drug-resistant epilepsy
This study tests whether structural changes in the hypothalamus relate to cardiac autonomic dysfunction in adults with drug-resistant epilepsy.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Advanced 7T fMRI for brain function in epilepsy and brain injuries
This study tests ultra-high-field brain scans at 7T to see if they can better map brain function in adults with epilepsy or brain lesions and in healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.